- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
HHS Will Enforce Disputed Rule Limiting Orphan Exclusion from 340B Drug Discounts
HHS is moving forward with its plan to allow certain hospitals to receive discounts on orphan drugs when they are used for non-orphan conditions despite a court ruling that said the agency did not have the authority to do so.
HHS is moving forward with its plan to allow certain hospitals to receive discounts on orphan drugs when they are used for non-orphan conditions despite a court ruling that said the agency did not have the authority to do so.
The government this week updated a Web page with information about the orphan-drug exclusion rule, asserting that the U.S. District Court for the District of Columbia's ruling in May did not in fact invalidate HHS' interpretation. The rule applies to four types of hospitals that participate in the 340B federal drug discount program, which gives discounts on covered outpatient drugs to healthcare providers that serve large numbers of low-income and indigent patients.
The Health Resources and Services Administration, the HHS agency that administers the 340B program, said participating providers and manufacturers “should attempt to work out any issues in good faith” prior to the start of the new quarter July 1. Manufacturers that do not comply may be required to refund covered hospitals entities or have agreements terminated, an HRSA spokesman said in a statement.
Read the full story here: http://bit.ly/1uDh2R7
Source: Modern Healthcare
Incorporating Discussions of Cannabis Use Into Oncology Care Visits
September 15th 2024The legalization of recreational marijuana in Minnesota has created daily conversations about how to incorporate the use of cannabis into treatment plans for patients with cancer, explained Marie Parish, PharmD, BCOP, of Mayo Clinic.
Read More
How Can Digital Care Programs Aid Those With Chronic Musculoskeletal Pain?
June 9th 2020On this episode of Managed Care Cast, we speak with Jeffrey Krauss, MD, chief medical officer of Hinge Health and Stanford Clinical assistant professor, about the efficacy of a 12-week digital care program aimed to reduce lower back and knee pain in a real-world population.
Listen
Understanding the Impact of Inappropriate Opioid Prescribing Practices
April 19th 2019Deaths from drug overdoses have become the leading cause of death for Americans under age 50, which can largely be attributed to prescription opioids. Due to the role of prescription opioids, understanding prescribing patterns and identifying inappropriate prescribing are crucial for changing the course of the epidemic.
Listen
How Patients Think About Pain May Impact Activity Levels, Study Says
December 22nd 2020The researchers said their results have potential implications for pain management and wellness in older adults, and they suggest that pain catastrophizing could be an important therapeutic target for interventions and pain treatment.
Read More
